AI assistant
NANOCO GROUP PLC — Director's Dealing 2019
Jun 26, 2019
4931_dirs_2019-06-26_ad090e7e-731a-40fc-9812-e26fbfaa02c6.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 5414D
Nanoco Group PLC
26 June 2019
26 June 2019
NANOCO GROUP PLC
("Nanoco", the "Group", or the "Company")
Director/PDMR Shareholding
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, has been notified that members of the Board of Directors bought ordinary shares of 10p each in the Company as set out below. The small sale by the Chairman was designed to move the larger net purchase into one investment fund.
| PDMR | Role | Shares | Average price |
| Dr Christopher Richards | Chairman | 350,000 Purchase 63,909 Sale |
13.3p 13.3p |
| Dr Michael Edelman | CEO | 198,000 Purchase | 12.71p |
| Dr Nigel Picket | CTO | 189,425 Purchase | 13.12p |
| Dr Alison Fielding | Non-Executive Director | 119,261 Purchase | 12.6475p |
| Brian Tenner | COO & CFO | 379,689 Purchase | 13.1p |
| Total (Net) Purchases | 1,172,466 Net Purchase |
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification of Dealing Form
1.
Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")
a)
Name
Dr CHRISTOPHER RICHARDS
2.
Reason for the notification: PURCHASE OF ORDINARY SHARES
a)
Position /status
CHAIRMAN
b)
Initial notification / amendment
INITIAL NOTIFICATION
3.
Details of the Issuer
a)
Name
NANOCO GROUP PLC
b)
LEI code
213800HOSJEZO1KOCV33
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Type of instrument:
Identification code
ORDINARY SHARES OF 1O PENCE EACH ("ORDINARY SHARES")
ISIN: GB00B01JLR99
b)
Nature of the transaction
PURCHASE OF ORDINARY SHARES
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 13.3p | 350,000 |
d)
Aggregated information:
- Aggregated volume
- Price
| Price(s) | Volume(s) |
| 13.3p | 350,000 |
e)
Date of the transaction
26 June 2019
f)
Place of the transaction
LONDON STOCK EXCHANGE
1.
Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")
a)
Name
Dr CHRISTOPHER RICHARDS
2.
Reason for the notification: SALE OF ORDINARY SHARES
a)
Position /status
CHAIRMAN
b)
Initial notification / amendment
INITIAL NOTIFICATION
3.
Details of the Issuer
a)
Name
NANOCO GROUP PLC
b)
LEI code
213800HOSJEZO1KOCV33
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Type of instrument:
Identification code
ORDINARY SHARES OF 1O PENCE EACH ("ORDINARY SHARES")
ISIN: GB00B01JLR99
b)
Nature of the transaction
SALE OF ORDINARY SHARES
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 13.3p | 63,909 |
d)
Aggregated information:
- Aggregated volume
- Price
| Price(s) | Volume(s) |
| 13.3p | 63,909 |
e)
Date of the transaction
26 June 2019
f)
Place of the transaction
LONDON STOCK EXCHANGE
1.
Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")
a)
Name
Dr MICHAEL EDELMAN
2.
Reason for the notification: PURCHASE OF ORDINARY SHARES
a)
Position /status
CHIEF EXECUTIVE OFFICER
b)
Initial notification / amendment
INITIAL NOTIFICATION
3.
Details of the Issuer
a)
Name
NANOCO GROUP PLC
b)
LEI code
213800HOSJEZO1KOCV33
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Type of instrument:
Identification code
ORDINARY SHARES OF 1O PENCE EACH ("ORDINARY SHARES")
ISIN: GB00B01JLR99
b)
Nature of the transaction
PURCHASE OF ORDINARY SHARES
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 12.75 12.70 |
39,600 158,400 |
d)
Aggregated information:
- Aggregated volume
- Price
| Price(s) | Volume(s) |
| 12.71p | 198,000 |
e)
Date of the transaction
26 June 2019
f)
Place of the transaction
LONDON STOCK EXCHANGE
1.
Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")
a)
Name
Dr NIGEL PICKETT
2.
Reason for the notification: PURCHASE OF ORDINARY SHARES
a)
Position /status
CHIEF TECHNOLOGY OFFICER
b)
Initial notification / amendment
INITIAL NOTIFICATION
3.
Details of the Issuer
a)
Name
NANOCO GROUP PLC
b)
LEI code
213800HOSJEZO1KOCV33
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Type of instrument:
Identification code
ORDINARY SHARES OF 1O PENCE EACH ("ORDINARY SHARES")
ISIN: GB00B01JLR99
b)
Nature of the transaction
PURCHASE OF ORDINARY SHARES
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 13.12p | 189,425 |
d)
Aggregated information:
- Aggregated volume
- Price
| Price(s) | Volume(s) |
| 13.12p | 189,425 |
e)
Date of the transaction
26 June 2019
f)
Place of the transaction
LONDON STOCK EXCHANGE
1.
Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")
a)
Name
Dr ALISON FIELDING
2.
Reason for the notification: PURCHASE OF ORDINARY SHARES
a)
Position /status
NON-EXECUTIVE DIRECTOR
b)
Initial notification / amendment
INITIAL NOTIFICATION
3.
Details of the Issuer
a)
Name
NANOCO GROUP PLC
b)
LEI code
213800HOSJEZO1KOCV33
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Type of instrument:
Identification code
ORDINARY SHARES OF 1O PENCE EACH ("ORDINARY SHARES")
ISIN: GB00B01JLR99
b)
Nature of the transaction
PURCHASE OF ORDINARY SHARES
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 12.6475p | 119,261 |
d)
Aggregated information:
- Aggregated volume
- Price
| Price(s) | Volume(s) |
| 12.6475p | 119,261 |
e)
Date of the transaction
26 June 2019
f)
Place of the transaction
LONDON STOCK EXCHANGE
1.
Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")
a)
Name
BRIAN TENNER
2.
Reason for the notification: PURCHASE OF ORDINARY SHARES
a)
Position /status
CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER
b)
Initial notification / amendment
INITIAL NOTIFICATION
3.
Details of the Issuer
a)
Name
NANOCO GROUP PLC
b)
LEI code
213800HOSJEZO1KOCV33
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Type of instrument:
Identification code
ORDINARY SHARES OF 1O PENCE EACH ("ORDINARY SHARES")
ISIN: GB00B01JLR99
b)
Nature of the transaction
PURCHASE OF ORDINARY SHARES
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 13.1p | 379,689 |
d)
Aggregated information:
- Aggregated volume
- Price
| Price(s) | Volume(s) |
| 13.1p | 379,689 |
e)
Date of the transaction
26 June 2019
f)
Place of the transaction
LONDON STOCK EXCHANGE
This announcement contains inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014.
For further information, please contact:
Nanoco Group PLC:
Michael Edelman, CEO +44 (0) 161 603 7900
Brian Tenner, COO & CFO +44 (0) 161 603 7900
Caroline Watson, Investor Relations Manager +44 (0) 7799 897 357
MHP Communications: +44 (0) 203 128 8570
Reg Hoare
Giles Robinson
Pete Lambie
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHCKADDQBKDNAB